Who Paid My Doc
Jonathan Philpott
Thoracic Surgery (Cardiothoracic Vascular Surgery) Honolulu, HI Medical Doctor
NPI 1457353229 CMS profile 66068
3288 Moanalua Rd, Honolulu, HI 96819
General payments
$83,632
Research payments
$26,789
Ownership & investment interest
$0
Research they led as principal investigator
$130,441
Through program year 2025, Jonathan Philpott of Honolulu, HI is reported in the CMS Open Payments database as having received $83,632 across 109 general payments and $26,789 in research payments paid to them. Separately, studies naming them as principal investigator received $130,441 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 94th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
14 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $110 | 2 | |
| 2025 | Research | $3,950 | 3 | |
| 2024 | General | $184 | 7 | |
| 2024 | Research | $1,400 | 3 | |
| 2023 | General | $198 | 2 | |
| 2023 | Research | $5,950 | 8 | |
| 2022 | General | $401 | 6 | |
| 2022 | Research | $3,850 | 5 | |
| 2021 | General | $12,786 | 13 | |
| 2021 | Research | $3,938 | 8 | |
| 2020 | General | $7,623 | 16 | |
| 2020 | Research | $4,551 | 12 | |
| 2019 | General | $62,331 | 63 | |
| 2019 | Research | $3,150 | 6 |
Beside peers
- Jonathan Philpott
- Thoracic Surgery (Cardiothoracic Vascular Surgery) median
- Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
- National median
In program year 2025, general payments to Jonathan Philpott were reported at $110. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.
Show as a table
| Year | Jonathan Philpott | Thoracic Surgery (Cardiothoracic Vascular Surgery) median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $62,331 | $886 | $178–$3,167 | $163 |
| 2020 | $7,623 | $341 | $108–$1,605 | $114 |
| 2021 | $12,786 | $453 | $125–$1,886 | $132 |
| 2022 | $401 | $695 | $180–$2,566 | $149 |
| 2023 | $198 | $745 | $205–$2,662 | $160 |
| 2024 | $184 | $799 | $214–$2,967 | $164 |
| 2025 | $110 | $791 | $208–$3,074 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
154 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Thoracic Surgery (Cardiothoracic Vascular Surgery) in Hawaii
Practitioners in the same specialty and state, ranked by reported value.
All Thoracic Surgery (Cardiothoracic Vascular Surgery)
Everyone recorded under this specialty, nationwide.
Doctors in Hawaii
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.